Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Current Deferred Revenue: 2014-2022

Historic Current Deferred Revenue for HUTCHMED (China) (HCM) over the last 8 years, with Dec 2022 value amounting to $13.3 million.

  • HUTCHMED (China)'s Current Deferred Revenue fell 2.72% to $46.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $46.8 million, marking a year-over-year decrease of 2.72%. This contributed to the annual value of $13.3 million for FY2022, which is N/A change from last year.
  • According to the latest figures from FY2022, HUTCHMED (China)'s Current Deferred Revenue is $13.3 million, which was up 735.75% from $1.6 million recorded in FY2020.
  • Over the past 5 years, HUTCHMED (China)'s Current Deferred Revenue peaked at $13.3 million during FY2022, and registered a low of $1.6 million during FY2020.
  • Its 2-year average for Current Deferred Revenue is $7.5 million, with a median of $7.5 million in 2020.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first spiked by 96.14% in 2018, then fell by 24.17% in 2020.
  • Yearly analysis of 4 years shows HUTCHMED (China)'s Current Deferred Revenue stood at $2.5 million in 2018, then dropped by 17.09% to $2.1 million in 2019, then dropped by 24.17% to $1.6 million in 2020, then reached $13.3 million in 2022.